Clinical trial

Study to Assess the Safety, Tolerability and Pharmacokinetic Profile of MNS075…

NCT00474799 · Javelin Pharmaceuticals, Industry · Completed

Key facts

NCT number NCT00474799
Title Study to Assess the Safety, Tolerability and Pharmacokinetic Profile of MNS075 (Intranasal Morphine)
Official title An Open Label, Randomized, Single Center, Repeat Dose Study to Assess the Safety, Tolerability and Pharmacokinetic Profile of MNS075 (Intranasal Morphine) in Opioid naïve, Healthy Adult Volunteers
Lead sponsor Javelin Pharmaceuticals, Industry
Status Completed
Phase Phase 1
Study type Interventional
Conditions Healthy
Intervention type Drug
Interventions MNS075
Enrollment 32
Start date Jan 1, 2007
Primary completion Feb 1, 2007
Completion Feb 1, 2007
First posted May 17, 2007
Last update posted Jan 14, 2008
Countries United States

At a glance

  • 1–9 Study sites
  • No Results posted
  • None Linked FDA submissions

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About ClinicalTrials.gov studies

ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.

Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date:

Browse all ClinicalTrials.gov studies